%0 Journal Article
%T Biomarkers France: a first and distinctive step in assessing the impact of non-small cell lung cancer (NSCLC) patients routine molecular profiling
%A Denis Moro-Sibilot
%A Dominique Maraninchi
%A Fabrice Barlesi
%A Jean-Charles Soria
%A Norbert Ifrah
%J SCIE-indexed Journal
%D 2016
%R 10.21037/9529
%X The French Cooperative Thoracic Intergroup (IFCT) recently published the results of the Biomarkers France study, the largest nationwide program of molecular profiling for non-small cell lung cancer (NSCLC) patients (1). As highlighted in the three editorials published by Translational Cancer Research regarding these results, the Biomarkers France study not only shows that a routine molecular profiling is already feasible for all of our advanced NSCLC patients, but also that identification of a molecular alteration changes their outcomes by decreasing their risk of death by 22%
%U http://tcr.amegroups.com/article/view/9529/html